Effect of CPAP withdrawal on BP in OSA: data from three randomized controlled trials
However, this combination requires careful monitoring by your doctor for potential side effects and drug interactions
Evidence also shows that treatment in these areas can help reduce the risks of heart disease and cognitive decline over the long term
We understand that individual results may vary, and we are committed to helping you set realistic expectations and achieve lasting success through expert, compassionate care
Tirzepatide produces roughly 20% weight loss in trials against about 14% for Novos semaglutide, and retatrutide stretches the distance further
Hojberg PV, Vilsboll T, Rabol R, Knop FK, Bache M, Krarup T, Holst JJ, Madsbad S